CODX · Co-Diagnostics Inc
United States · RS rating 3 · As of 2026-10-14
| Price | 0.76 USD |
|---|---|
| 1-day change | -28.2% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 5 / 2 / 3 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 14 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +64.0% |
| Sales growth Q/Q | +81.5% |
| Distance from 52-week high | +98.0% |
| Market cap (USD) | $6.2M |